hims semaglutide injection Novo is suing & Hers to halt obesity drug copycats Semaglutide Wars: Novo Sues Hims

Those with anemia due to B12 deficiency

Fasting appetite scores were significantly lower with semaglutide (P = 0.0023)

As of July 2026, Henry Meds lists injectable compounded semaglutide at $297/month month-to-month (the advertised $197/month is its 12-month prepaid-in-full rate), oral sublingual semaglutide at $249/month, oral tirzepatide dissolving tablets as a 3-month supply at $1,047 ($891 paid in full), liraglutide at $179/month, and phentermine at $149/month

Better Eating Patterns: Semaglutide promotes steadier energy levels throughout the day by supporting normal insulin function

Oral Non-Peptide GLP-1 Receptor Agonists Market Key Players Analysis - Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Roche Holding AG

While Medicare is currently prohibited by law from covering medications used specifically for weight loss, Medicare spending on these drugs is currently skyrocketing given their high price and use for diabetes and to reduce cardiovascular risk